Cyclobenzaprine Hydrochloride
Product Images NDC 21695-036

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 21695-036). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label (036)

Package Label (036)
This is a product label for tablets of the medication Cyclobenzaprine HCI, with a strength of 5mg each. The label includes lot numbers, expiration dates, and a product code. It also contains a warning to keep the tablets out of reach of children and to store them at a temperature between 59-86°F (15-30°C). The tablets were manufactured by Cadita Pharmaceuticals Inc. in Salisbury, Maryland, USA.*
FDA Label Image

Chemical Structure (Cyclobenzaprine H 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.